Dow Up0.51% Nasdaq Up0.24%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM
1.43 Up 0.02(1.42%) Nov 21, 4:00PM EST
|After Hours : 1.43 Up 0.00 (0.01%) Nov 21, 4:45PM EST
Insider TransactionsGet Insider Transactions for:
Net Share Purchase Activity
Insider Purchases - Last 6 Months
 SharesTrans
PurchasesN/A0
SalesN/A0
Net Shares Purchased
(Sold)
N/A0
Total Insider Shares Held8.99MN/A
% Net Shares Purchased
(Sold)
0%N/A
Net Institutional Purchases - Prior Qtr to Latest Qtr
 Shares
Net Shares Purchased
(Sold)
710,823
% Change in Institutional Shares Held2.28%
Data provided by Thomson Financial


Insider Transactions Reported - Last Two Years
DateInsiderSharesTypeTransactionValue*
Oct 31, 2014FUSSEY SHELLEY PMOfficer5,362DirectAcquisition (Non Open Market) at $1.36 per share.7,292
Oct 31, 2014KING STEVEN WOfficer3,280DirectAcquisition (Non Open Market) at $1.36 per share.4,460
Apr 30, 2014FUSSEY SHELLEY PMOfficer6,571DirectAcquisition (Non Open Market) at $1.11 per share.7,293
Apr 30, 2014KING STEVEN WOfficer4,020DirectAcquisition (Non Open Market) at $1.11 per share.4,462
Apr 29, 2014KING STEVEN WOfficer25,662DirectDisposition (Non Open Market) N/A
Oct 31, 2013KING STEVEN WOfficer4,131DirectAcquisition (Non Open Market) at $1.08 per share.4,461
Oct 31, 2013FUSSEY SHELLEY PMOfficer6,752DirectAcquisition (Non Open Market) at $1.08 per share.7,292
Oct 15, 2013KING STEVEN WOfficer100,000DirectAcquisition (Non Open Market) N/A
Apr 30, 2013FUSSEY SHELLEY PMOfficer10,481DirectAcquisition (Non Open Market) at $0.71 per share.7,441
Apr 30, 2013KING STEVEN WOfficer6,516DirectAcquisition (Non Open Market) at $0.71 per share.4,626
Apr 30, 2013LYTLE PAUL JOfficer11,988DirectAcquisition (Non Open Market) at $0.71 per share.8,511
Data provided by EDGAR Online
* = Where indicated, some values are estimates.
1= Potential proceeds estimated by the filer.
2= Estimated based on the average of multiple prices reported.
3= Multiple dates reported. Most recent date shown.

Currency in USD.



All Major Holders - Insider Roster